Clinical Trials Logo

Clinical Trial Details — Status: Suspended

Administrative data

NCT number NCT05755464
Other study ID # 1946
Secondary ID
Status Suspended
Phase
First received
Last updated
Start date September 20, 2018
Est. completion date September 20, 2024

Study information

Verified date February 2023
Source Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Since subjects with Down Syndrome (DS) have different and variable levels of intellectual deficit, in approaching the patient with DS and before evaluating the different therapeutic strategies and carrying out a dental and orthodontic treatment, an initial analysis would be useful the patient's level of cooperation. The hypothesis underlying the study is the possibility of predicting the degree of success of dental and orthodontic treatment in the patient with Down's Syndrome by completing an evaluation form by the clinician. The general objective of the study is to test the effectiveness of the module in assessing and quantifying the degree of patient collaboration. This form is filled in entirely during the first visit and updated in subsequent sessions in conjunction with the different operational phases. Based on the score obtained by the patient, the clinician can hypothesize the degree of cooperation during the operative sessions and compliance with the indications provided. Therefore, the evaluation of the score obtained will guide the clinician in choosing the type of therapy that will have the least risk of failure because this will be chosen having evaluated not only the dental and/or orthodontic therapeutic needs, but also the real ability of the patient to collaborate.


Description:

In the planning and management of dental and/or orthodontic treatments aimed at people with intellectual disabilities, the role of the clinician and his ability to empathize with the patient in order to obtain collaboration in treatment is fundamental. For these reasons it is necessary that, before planning the therapy, he can carry out a careful and complete evaluation of the behavioral profile that these subjects manifest. Given the scarce presence in the literature of studies relating to an a priori evaluation of patient collaboration, this study aims to propose an objective and reproducible protocol to evaluate the patient's behavioral typology at the beginning of the treatment relationship, so as to improve the quality of the diagnosis and subsequent treatment of the patient by directing the clinician towards the most appropriate and effective treatment. Down syndrome (DS), which our study deals with, is the result of trisomy of chromosome 21, and is considered the main genetic cause of mental disability. Trisomy of chromosome 21 affects both physical and cognitive development and results in a characteristic behavioral phenotype; however, the individuals concerned show a great variability of behavior in relation to the severity of the specific deficit, and this affects the chances of success of a dental treatment and, if necessary, the success and stability in the short and long term long-term orthodontic treatment. In subjects with Down syndrome orofacial dyskinesia has a high prevalence and consists of a set of abnormal and involuntary movements of the facial muscles and/or masticatory muscles, which determine mandibular movements in protrusion and bruxism. Due to the marked orofacial hypotonia, the subject encounters considerable difficulties in sucking, swallowing, speaking and chewing from the first years of life. For this reason, an intervention aimed at solving the problems relating to swallowing, phonation, breathing and chewing is necessary, since these anomalies can preclude the possibility of a normal integration into the social context and relationship life by these subjects. Furthermore, obstructive sleep apnea syndrome (OSAS) is significantly more prevalent among children with DS than in the general population, and a bidirectional and complex link between sleep disturbances and pediatric health has been demonstrated: sleep disturbances they have been associated with the development of obesity and cardiovascular abnormalities, epilepsy, autism spectrum disorders, attention deficit hyperactivity disorder (ADHD), mood and anxiety disorders, and a wide range of neurocognitive problems. At the level of the oral cavity, a greater prevalence of oligodontia has been demonstrated in subjects with Down syndrome: the teeth that are most frequently missing are the third molars, followed by the second premolars and the incisors. Some patients may also have deciduous teeth even in adulthood. Individuals with Down syndrome also have microdontia affecting all teeth except the upper first molars and lower incisors. A higher prevalence of class III malocclusion can also be observed in these individuals compared to the general population; this could be attributed to altered skull-to-bone ratios, reduced size of the dental arches, and decreased jaw size in patients with Down syndrome. Another interesting fact is that these subjects show a higher incidence of fractures of the dental elements than the general population, mainly affecting the upper incisors, due to the greater frequency of severe maxillary overjet, class II-I division malocclusion, short or incompetent superior and a greater accident proneness. At the craniofacial level in the subject with DS the height of the palate is significantly reduced and the presence of a "torus palatine" can easily be found which gives the palate a characteristic "W" shape; this is frequently associated with upper airway obstruction. The presence in such subjects of a high arched palate and the reduction of the nasal septum contribute to a considerable narrowing of the nasal antrum and therefore limit the development of the upper airways. Because of this, children with DS are forced to breathe through their mouths and maintain a low tongue posture and are therefore termed oral breathers. Therefore, the lack of ventilation of the upper airways does not cause the flattening action of the floor of the nasal cavities operated by the air flow. In oral respirator it is also important to evaluate the state of the adenoids, the presence of hypertrophic tonsils and any allergic diseases (allergic rhinitis, bronchial asthma). Furthermore, in a study by Oliveira et al. it was observed that at the oral level there was a direct correlation between the presence of airway infections in the 6 months prior to the trial and an increased risk of 2.47 of developing posterior crossbite. Untreated oral respiratory subjects may develop a distinctive facial profile, with long narrow faces, narrow jaws, a high-arched palate with dental malocclusion, a gingival smile, and skeletal class III. For these reasons, an early and specific orthodontic treatment is essential: the expansion of the palate in fact determines an increase in the nasal volume and in the ability to implement nasal rather than oral breathing. For these reasons, an adequate medical approach, combined with early dental intervention, can lead to a reduction in the prevalence of malocclusions in subjects with DS, with a consequent beneficial effect on the development of these subjects. In order to improve the oral health of these individuals, defined as "special needs patients", it is essential that the public health services that deal with oral health introduce intervention methods dedicated to the prevention and treatment of malocclusions. It is therefore essential to understand the panorama of the dental needs of people with disabilities in order to ensure treatments that can help this component of the population overcome difficulties and improve their growth opportunities and quality of life. In these subjects it is possible to find deviations from the norm with regard to the size, shape or position of the maxilla and mandible. The types of malocclusion most commonly found in these subjects are dental crowding, open bite, mono- or bilateral crossbite and skeletal class III. Malocclusion in these subjects not only negatively affects functions such as chewing, language, sucking and swallowing, but also has important consequences on the psychological profile due to unacceptable dental aesthetics. The implementation of orthodontic treatments in subjects with DS has the objective of restoring normal masticatory function and of creating greater resistance to the disease and an overall improvement of the personal appearance, which contributes positively to the physical and mental well-being of the subject. In fact, analyzing the picture in relation to the aesthetic aspect, it can be observed how the presence of bad breath, dental malposition, trauma, gum bleeding, open mouth posture and excessive salivation can lead to feelings of compassion or repugnance and discrimination from others individuals, thus accentuating a tendency to isolate these subjects from the life of society. The patient with Down syndrome represents an ideal candidate to carry out a study aimed at evaluating the collaboration in dental and orthodontic treatments, since he presents a series of peculiar orthodontic anomalies, such as 3rd class malocclusion, open bite, cross bite and agenesis; it has also been observed that subjects with DS show a very different degree of collaboration based on the severity of the developmental and behavioral deficits. Consequently, some of them will show a more positive and favorable attitude towards dental care, while others will be treatable with more difficulty or treatable exclusively in partial or total sedation. For these reasons, although the need for orthodontic treatment is often present, this is not always feasible until all the treatment objectives have been achieved: in fact, often, due to the poor collaboration of patients with Down syndrome, partial objectives are established and /or minimally invasive orthodontic means are used with limited results.


Recruitment information / eligibility

Status Suspended
Enrollment 100
Est. completion date September 20, 2024
Est. primary completion date September 20, 2021
Accepts healthy volunteers No
Gender All
Age group 9 Years to 16 Years
Eligibility Inclusion Criteria: - Down Syndrome - Need of Dental treatment - malocclusion Exclusion Criteria: - other existing pathologies

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Italy Università Cattolica del Sacro Cuore Rome

Sponsors (1)

Lead Sponsor Collaborator
Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary To evaluate the effectiveness of a module designed to evaluate the level of collaboration of the dental patient with DS. The aspects that, during the procedures, are indicative of the collaboration, translated into numerical values are counted. 3 years
See also
  Status Clinical Trial Phase
Recruiting NCT04854122 - Blood Flow Regulation in Individuals With Down Syndrome - Training Study N/A
Completed NCT04020302 - Self-Monitoring Shopping Intervention N/A
Recruiting NCT01950624 - DS-Connect {TM}: The Down Syndrome Registry
Completed NCT04751136 - the Effect of Cerebrolysin on Physical and Mental Functions of Down Syndrome Phase 2
Completed NCT04767412 - Inspiratory Muscle Training and Physical Fitness in Children With Down Syndrome Randomized Control Trial N/A
Not yet recruiting NCT04037579 - Protocol for a Non-randomized Survey in Down Syndrome People Who Practice Sports. Self and Observers´ Perception.
Completed NCT04536506 - Bobath and Vojta Therapy for DS N/A
Completed NCT02882698 - Performance Analysis in Down Syndrome on Mobile Phone N/A
Completed NCT01791725 - A 4-Week Safety Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia Phase 2
Unknown status NCT01975545 - Fluor Varnish With Silver Nanoparticles for Dental Remineralization in Patients With Trisomy 21 Phase 2
Completed NCT01808508 - Obstructive Sleep Apnea and Neurocognitive and Cardiovascular Function in Children With Down Syndrome N/A
Terminated NCT00754013 - Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10 Phase 3
Terminated NCT00754052 - Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17 Phase 3
Completed NCT01256112 - Parent Supported Weight Reduction in Down Syndrome N/A
Completed NCT01313325 - Hippotherapy to Improve the Balance of Children With Movement Disorders N/A
Completed NCT01594346 - Multicenter Vitamin E Trial in Aging Persons With Down Syndrome Phase 3
Completed NCT05343468 - Life Skills Improved in Children With Down Syndrome After Using Assistive Technology N/A
Recruiting NCT04022460 - Using Personal Mobile Technology to Identify Obstructive Sleep Apnea in Children With Down Syndrome (UPLOAD)
Completed NCT04818437 - Effect of Core Stability Exercises and Balance Training in Postural Control Among Down Syndrome N/A
Completed NCT03192540 - The Impact of an 8-week Supported Exercise Program on Fitness and Symptoms in Adolescents With Down Syndrome N/A